FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 308:1454-1457 June 16, 1983 Number 24 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We examined the relation between coffee consumption and levels of serum total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglycerides in a population of 7213 women and 7368 men between the ages of 20 and 54 years. Coffee consumption was positively associated with levels of total cholesterol and triglycerides in both sexes and was inversely associated with levels of HDL cholesterol in women. The coffee-cholesterol relation remained strong and statistically significant (P less than 0.0001 in a covariance analysis) after adjustment for age, logarithm of body-mass index, physical activity in leisure time, cigarette smoking, and alcohol consumption. After adjustment for all covariates, the total cholesterol level was 5.56 +/- 0.05 mmol per liter (mean +/- S.E.) in men drinking less than one cup of coffee a day, as compared with 6.23 +/- 0.03 mmol per liter in those consuming more than nine cups a day. The corresponding figures for women were 5.32 +/- 0.05 and 5.92 +/- 0.04 mmol per liter. None of the other variables considered could explain this relation. We conclude that coffee consumption is a major contributor to the variation in levels of total cholesterol.

This article has been cited by other articles:

• Ricketts, M.-L., Boekschoten, M. V., Kreeft, A. J., Hooiveld, G. J. E. J., Moen, C. J. A., Muller, M., Frants, R. R., Kasanmoentalib, S., Post, S. M., Princen, H. M. G., Porter, J. G., Katan, M. B., Hofker, M. H., Moore, D. D. (2007). The Cholesterol-Raising Factor from Coffee Beans, Cafestol, as an Agonist Ligand for the Farnesoid and Pregnane X Receptors. Mol. Endocrinol. 21: 1603-1616 [Abstract] [Full Text]  
• Happonen, P., Voutilainen, S., Salonen, J. T. (2004). Coffee Drinking Is Dose-Dependently Related to the Risk of Acute Coronary Events in Middle-Aged Men. J. Nutr. 134: 2381-2386 [Abstract] [Full Text]  
• Lupton, B. S., Fonnebo, V., Sogaard, A. J. (2003). The Finnmark Intervention Study: is it possible to change CVD risk factors by community-based intervention in an Arctic village in crisis?. Scand J Public Health 31: 178-186 [Abstract]  
• Kleemola, P., Jousilahti, P., Pietinen, P., Vartiainen, E., Tuomilehto, J. (2000). Coffee Consumption and the Risk of Coronary Heart Disease and Death. Arch Intern Med 160: 3393-3400 [Abstract] [Full Text]  
• Hegarty, V. M, May, H. M, Khaw, K.-T. (2000). Tea drinking and bone mineral density in older women. Am. J. Clin. Nutr. 71: 1003-1007 [Abstract] [Full Text]  
• Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A., Zvartau, E. E. (1999). Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use. Pharmacol. Rev. 51: 83-133 [Abstract] [Full Text]  
• Halvorsen, B., Ranheim, T., Nenseter, M. S., Huggett, A. C., Drevon, C. A. (1998). Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. J. Lipid Res. 39: 901-912 [Abstract] [Full Text]  
• Post, S. M., de Wit, E. C. M., Princen., H. M. G. (1997). Cafestol, the Cholesterol-Raising Factor in Boiled Coffee, Suppresses Bile Acid Synthesis by Downregulation of Cholesterol 7{alpha}-Hydroxylase and Sterol 27-Hydroxylase in Rat Hepatocytes. Arterioscler. Thromb. Vasc. Bio. 17: 3064-3070 [Abstract] [Full Text]  
• Rustan, A. C., Halvorsen, B., Huggett, A. C., Ranheim, T., Drevon, C. A. (1997). Effect of Coffee Lipids (Cafestol and Kahweol) on Regulation of Cholesterol Metabolism in HepG2 Cells. Arterioscler. Thromb. Vasc. Bio. 17: 2140-2149 [Abstract] [Full Text]  
• Fonnebo, V. (1995). The Tromso Study: Does Husband's Religion Influence the Lifestyle of Seventh-Day Adventist Women?. Scand J Public Health 23: 85-87  
• Wilson, P. W. F., Garrison, R. J., Kannel, W. B., McGee, D. L., Castelli, W. P. (1989). Is Coffee Consumption a Contributor to Cardiovascular Disease? Insights From the Framingham Study. Arch Intern Med 149: 1169-1172 [Abstract]  
• Hirsch, A. T., Gervino, E. V., Nakao, S., Come, P. C., Silverman, K. J., Grossman, W. (1989). The Effect of Caffeine on Exercise Tolerance and Left Ventricular Function in Patients with Coronary Artery Disease. ANN INTERN MED 110: 593-598 [Abstract]  
• Knutsen, S. F., Knutsen, R. (1989). The Tromso Heart Study: Family Approach to Intervention on CHD : sFeasibility of Risk Factor Reduction in High-risk Persons--Project Descriptions. Scand J Public Health 17: 109-119 [Abstract]  
• Jacobsen, B. K., Thelle, D. S. (1988). The Tromso Heart Study: Responders and Non-responders to a Health Questionnaire, Do They Differ?. Scand J Public Health 16: 101-104 [Abstract]  
• Superko, H. R., Bachorik, P. S., Wood, P. D. (1986). High-Density Lipoprotein Cholesterol Measurements: A Help or Hindrance in Practical Clinical Medicine?. JAMA 256: 2714-2717 [Abstract]  
• Williams, P. T., Wood, P. D., Vranizan, K. M., Albers, J. J., Garay, S. C., Taylor, C. B. (1985). Coffee Intake and Elevated Cholesterol and Apolipoprotein B Levels in Men. JAMA 253: 1407-1411 [Abstract]